| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Fennec Pharmaceuticals Inc. (FENC) have been net sellers, shedding 112,545 shares worth roughly $1.3M on balance.
Counted by filing, the last 12 months brought no open-market purchases and 15 sales by 5 insiders worth about $2.2M. The 12 months before that brought 1 open-market purchase by 1 insider worth about $105K and 18 sales by 2 insiders worth about $951K.
Funds and other entities also made 3 sales worth about $9.7M in the last 12 months, not counted above.
14 of the 15 sales in the last 12 months were made under a Rule 10b5-1 trading plan; the rest were not.
The largest open-market purchase in the last two years was 15,000 shares by Jeffrey S. Hackman (Chief Executive Officer) at an average $6.97 on May 19, 2025, about $105K. Twelve months later FENC was up 28%.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 2.74M | $29.37M | - | |
| CFO | 248.6K | $2.66M | - | |
| Dir | 124.4K | $1.33M | - | |
| CEO | 70.8K | $758.0K | - | |
| Dir | 63.1K | $674.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Marco Maria Brughera | Director | Sale+OE10b5-1 | 15,545 | $10.29 | $159,958.05 | - | - | - | |
| Sep 1, 2026 | Rosty Raykov51 | Former Director | Sell10b5-1 | 10,000 | $12.11 | $121,100.00 | -7.4% | - | - | |
| Aug 31, 2026 | Pierre Sargis Sayad | Chief Medical Officer | Sell | 12,000 | $12.18 | $146,160.00 | -55.8% | - | - | |
| Aug 27, 2026 | Robert Andrade69 | Chief Financial Officer | Sale+OE10b5-1 | 75,000 | $11.78 | $883,500.00 | -25.6% | - | - | |
| Aug 3, 2026 | Rosty Raykov51 | Former Director | Sell10b5-1 | 10,000 | $9.58 | $95,800.00 | -7.1% | +14.2% | - | |
| Jul 1, 2026 | Rosty Raykov51 | Former Director | Sale+OE10b5-1 | 9,599 | $10.41 | $99,925.59 | -6.5% | +4.4% | - | |
| Jun 1, 2026 | Rosty Raykov51 | Director | Sale+OE10b5-1 | 9,747 | $9.62 | $93,766.14 | -7.0% | +25.0% | - | |
| May 11, 2026 | Chris A Rallis60 | Director | Sale+OE10b5-1 | 8,346 | $7.04 | $58,755.84 | -11.7% | +54.1% | - | |
| May 1, 2026 | Rosty Raykov51 | Director | Sale+OE10b5-1 | 10,781 | $6.47 | $69,753.07 | -8.2% | +51.5% | - | |
| Apr 1, 2026 | Rosty Raykov51 | Director | Sale+OE10b5-1 | 10,946 | $6.31 | $69,069.26 | -8.8% | +67.7% | - |